You might have heard about Ozempic® (semaglutide) and its link to thyroid tumors. So, does Ozempic® cause cancer? It doesn’t look like it. It can cause thyroid tumors in rats and mice, but more ...

Ozempic (semaglutide) carries a boxed warning for thyroid cancer based on animal studies. Here’s what to know about the drug’s cancer risk and what current research shows. Ozempic is a prescription ...

A recent study found a possible association between severe male infertility and an increased risk of thyroid and colorectal ...

TAMPA, Fla., Feb. 10, 2026 /PRNewswire/ -- With the rapid rise in use of GLP-1 receptor agonist medications such as Ozempic®, Wegovy®, and Mounjaro® for diabetes and weight loss, public concern has ...

Men who are infertile have twice the risk of colorectal cancer and three times the risk of thyroid cancer, new research shows ...

Hispanic patients exhibit higher thyroid malignancy rates than non-Hispanic patients despite similar TI-RADS and Bethesda scores.

A comprehensive analysis of clinical and preclinical data reveals that GLP-1 receptor agonists, previously suspected of increasing cancer risk, are generally safe and may even reduce the incidence of ...

Human cohort studies and meta-analyses have not shown increased incidence of common differentiated thyroid cancers with GLP-1 receptor agonist exposure. Rodent C-cell tumor signals underpin the boxed ...

Men with severely reduced fertility are at greater risk of developing other health conditions later in life. A research team from Lund University in Sweden has now shown that these men are also more ...

Origin in C cells renders disease calcitonin/CEA-secreting and non–iodine-avid, eliminating therapeutic utility of radioactive iodine and emphasizing early, definitive management. Clinical phenotypes ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: Semaglutide — the active ingredient in Ozempic® — causes thyroid tumors in rodents. But it’s unclear if this happens in humans.